Загрузка...
Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer
Central nervous system (CNS) metastases are common in patients with advanced non-small cell lung cancer (NSCLC), occurring in 24% to 44% of patients in the course of their disease and confer significant morbidity and mortality. Systemic therapies have been deemed ineffective in brain metastases (BM)...
Сохранить в:
| Опубликовано в: : | Transl Lung Cancer Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233881/ https://ncbi.nlm.nih.gov/pubmed/28149756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.09.03 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|